Statistics

Total Visits

Views
Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations3

File Visits

Downloads

Select a period of time:

Number of views in the range

Views
Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations3

Number of downloads in the range

Downloads

Views

Views
May 20250
June 20250
July 20250
August 20250
September 20250
October 20253
November 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Argentina2
Paraguay1
 

Top cities views

Views
Buenos Aires1
San Juan Bautista1